Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression.
Carolina Martínez-Ciarpaglini, Rita Barros, Carmelo Caballero, Hugo Boggino, Lorena Alarcón-Molero, Bárbara Peleteiro, Erika Ruiz-García, Edith Fernandez-Figueroa, Roberto Herrera-Goepfert, Consuelo Díaz-Romero, Rui Ferreira, Tessa S Groen-van Schooten, Cinthia Gauna, Rita Pereira, Daniel Cantero, Horacio Lezcano, Federico Esteso, Juan O Connor, Arnoldo Riquelme, Gareth I Owen, Marcelo Garrido, Juan Carlos Roa, Fiorella Ruiz-Pace, Ana Vivancos, Marc Diez-García, Maria Alsina, Judit Matito, Agatha Martin, Marina Gómez, Ester Castillo, Maria Vila, João Santos-Antunes, Andreia Costa, Florian Lordick, Judith Farrés, Brenda Palomar-De Lucas, Manuel Cabeza-Segura, Rosanna Villagrasa, Elena Jimenez-Martí, Ana Miralles-Marco, Rodrigo Dienstmann, Sarah Derks, Ceu Figueiredo, Andrés Cervantes, Fátima Carneiro, Tania Fleitas-Kanonnikoff
{"title":"Comprehensive histopathological analysis of gastric cancer in European and Latin America populations reveals differences in PDL1, HER2, p53 and MUC6 expression.","authors":"Carolina Martínez-Ciarpaglini, Rita Barros, Carmelo Caballero, Hugo Boggino, Lorena Alarcón-Molero, Bárbara Peleteiro, Erika Ruiz-García, Edith Fernandez-Figueroa, Roberto Herrera-Goepfert, Consuelo Díaz-Romero, Rui Ferreira, Tessa S Groen-van Schooten, Cinthia Gauna, Rita Pereira, Daniel Cantero, Horacio Lezcano, Federico Esteso, Juan O Connor, Arnoldo Riquelme, Gareth I Owen, Marcelo Garrido, Juan Carlos Roa, Fiorella Ruiz-Pace, Ana Vivancos, Marc Diez-García, Maria Alsina, Judit Matito, Agatha Martin, Marina Gómez, Ester Castillo, Maria Vila, João Santos-Antunes, Andreia Costa, Florian Lordick, Judith Farrés, Brenda Palomar-De Lucas, Manuel Cabeza-Segura, Rosanna Villagrasa, Elena Jimenez-Martí, Ana Miralles-Marco, Rodrigo Dienstmann, Sarah Derks, Ceu Figueiredo, Andrés Cervantes, Fátima Carneiro, Tania Fleitas-Kanonnikoff","doi":"10.1007/s10120-024-01578-3","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Gastric cancer (GC) burden is currently evolving with regional differences associated with complex behavioural, environmental, and genetic risk factors. The LEGACy study is a Horizon 2020-funded multi-institutional research project conducted prospectively to provide comprehensive data on the tumour biological characteristics of gastroesophageal cancer from European and LATAM countries.</p><p><strong>Material and methods: </strong>Treatment-naïve advanced gastroesophageal adenocarcinoma patients were prospectively recruited in seven European and LATAM countries. Formalin-fixed paraffin-embedded primary tumour endoscopic biopsy samples were collected and submitted for central morphological and immunohistochemical characterization and TP53 molecular assessment and Helicobacter pylori infection.</p><p><strong>Results: </strong>A total of 259 patients were included in the study: 137 (53%) from LATAM and 122 (47%) from Europe. Significant biological differences were detected between European and LATAM patients. Low representation of chromosomal instability (CIN) and HER2 positive cases were found in LATAM. MUC6 and PD-L1 were more frequently overexpressed in European cases, showing a significant correlation across the entire study population, with this association being especially pronounced in MMRdeficient cases. Both TP53 mutation by next-generation sequencing and p53 immunohistochemical aberrant pattern were linked with features associated with chromosomal instability. No regional differences were observed in H. pylori prevalence or abundance, indicating that the afore mentioned variations cannot be attributed to this factor.</p><p><strong>Conclusion: </strong>Our findings underscore a need for region-specific approaches in gastroesophageal cancer diagnosis and treatment. MUC6 emerges as a putative immune regulator that needs further investigation. Research tailored to the unique biological profiles in different global regions is crucial to effectively address the observed disparities.</p>","PeriodicalId":12684,"journal":{"name":"Gastric Cancer","volume":" ","pages":"160-173"},"PeriodicalIF":6.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11842524/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastric Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10120-024-01578-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/5 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Gastric cancer (GC) burden is currently evolving with regional differences associated with complex behavioural, environmental, and genetic risk factors. The LEGACy study is a Horizon 2020-funded multi-institutional research project conducted prospectively to provide comprehensive data on the tumour biological characteristics of gastroesophageal cancer from European and LATAM countries.
Material and methods: Treatment-naïve advanced gastroesophageal adenocarcinoma patients were prospectively recruited in seven European and LATAM countries. Formalin-fixed paraffin-embedded primary tumour endoscopic biopsy samples were collected and submitted for central morphological and immunohistochemical characterization and TP53 molecular assessment and Helicobacter pylori infection.
Results: A total of 259 patients were included in the study: 137 (53%) from LATAM and 122 (47%) from Europe. Significant biological differences were detected between European and LATAM patients. Low representation of chromosomal instability (CIN) and HER2 positive cases were found in LATAM. MUC6 and PD-L1 were more frequently overexpressed in European cases, showing a significant correlation across the entire study population, with this association being especially pronounced in MMRdeficient cases. Both TP53 mutation by next-generation sequencing and p53 immunohistochemical aberrant pattern were linked with features associated with chromosomal instability. No regional differences were observed in H. pylori prevalence or abundance, indicating that the afore mentioned variations cannot be attributed to this factor.
Conclusion: Our findings underscore a need for region-specific approaches in gastroesophageal cancer diagnosis and treatment. MUC6 emerges as a putative immune regulator that needs further investigation. Research tailored to the unique biological profiles in different global regions is crucial to effectively address the observed disparities.
期刊介绍：
Gastric Cancer is an esteemed global forum that focuses on various aspects of gastric cancer research, treatment, and biology worldwide.
The journal promotes a diverse range of content, including original articles, case reports, short communications, and technical notes. It also welcomes Letters to the Editor discussing published articles or sharing viewpoints on gastric cancer topics.
Review articles are predominantly sought after by the Editor, ensuring comprehensive coverage of the field.
With a dedicated and knowledgeable editorial team, the journal is committed to providing exceptional support and ensuring high levels of author satisfaction. In fact, over 90% of published authors have expressed their intent to publish again in our esteemed journal.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
